Nancy Wright
Pediatric Endocrinology · Tallahassee, FLNPI 1134144272
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $12,750 of the $19,961 with a category attached, or 63.9%. Arbor Pharmaceuticals, Inc. accounts for 69.9% of it on its own, with 22 other manufacturers making up the rest. Reporting peaked in 2020 at $10,038 and has fallen 80.1% since, to $1,993 in 2022.
Across 169 payments — averaging $118.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arbor Pharmaceuticals, Inc.$14K
- AbbVie$3K
- CGG Medical Inc$1K
- Xeris Pharmaceuticals, Inc.$301
- Novo Nordisk$280
- Tolmar Pharmaceuticals, Inc.$243
- plus $1K from 17 others
Across 24 payments — averaging $979.17 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Arbor Pharmaceuticals, Inc.$24K
What the payments were for
- Consulting fees$1791%
- Speaking & faculty fees$12,75064%
- Travel & lodging$2,92015%
- Food & beverage$2,74314%
- Education$1,3107%
- Other$590%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arbor Pharmaceuticals, Inc. | 21 | $13,958 |
| AbbVie | 36 | $2,933 |
| CGG Medical Inc | 1 | $1,200 |
| Xeris Pharmaceuticals, Inc. | 16 | $301 |
| Novo Nordisk | 16 | $280 |
| Tolmar Pharmaceuticals, Inc. | 29 | $243 |
| Ascendis Pharma Endocrinology Inc | 7 | $161 |
| Lilly USA, LLC | 6 | $110 |
| Dexcom, Inc. | 5 | $93 |
| Zealand Pharma US, Inc. | 3 | $72 |
| Abbott | 4 | $70 |
| Sanofi-aventis U.S. LLC | 1 | $66 |
| Endo Pharmaceuticals Inc. | 3 | $61 |
| Welch Allyn | 1 | $59 |
| AstraZeneca | 3 | $58 |
| Insulet Corporation | 3 | $55 |
| Lifescan, Inc. | 3 | $53 |
| Ferring Pharmaceuticals Inc. | 3 | $41 |
| Ultragenyx Pharmaceutical Inc. | 2 | $39 |
| BD | 1 | $34 |
| Medtronic | 2 | $29 |
| Tandem Diabetes Care, Inc. | 2 | $26 |
| IBSA Pharma Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Triptodur$13,730
- Lupron Depot$2,250
How this compares
$19,961 in reported general payments places this provider in the 85th percentile of 102 pediatric endocrinology providers in Florida.
Other pediatric endocrinology in Tallahassee
- Larry DeebTallahassee$26K
- Joshua YangOrlando$846K
- Henry RodriguezTampa$211K
- Dorothy ShulmanTampa$104K
- Michael HallerGainesville$102K
- Alejandro DiazMiami$101K
- Samuel FreedmanPembroke Pines$71K
- Jennifer MillerGainesville$57K
- Miladys Palau CollazoPort St Lucie$54K
- Laura JacobsenGainesville$36K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.